Strength in overseas markets and kick in oil price drives futures higher

Published 06-OCT-2020 09:28 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

The S&P/ASX 200 index (XJO) soared 150 points or 2.6% as it turned around all of Friday’s losses, as well as adding another 70 points.

The financial sector which has a strong index weighting given that it includes the four big banks and other large financial institutions had a significant impact on the rebound.

The four big banks were all up by about 4%, and Macquarie Group surged 3%.

Our big miners such as BHP and Rio Tinto added further momentum, assisted by oil stocks which rebounded after being hammered on Friday.

Oil Search, Beach Energy and Santos were up by 7.5%, 5.6% and 4.7% respectively, while energy services group Worley gained nearly 6%.

The ASX SPI200 futures index suggests this positive momentum will continue on Tuesday as it is up 28 points to 5954 points.

Given the strength in equities markets overnight and the strong performance from key commodities such as oil and gold, this could be on the cards.

However, bear in mind that much of yesterday’s gains were on the back of optimistic expectations regarding tonight’s budget which is expected to provide tax cuts, cash injections and stimulus packages for consumers and businesses.

The adage, ‘’buy the rumour, sell the fact’’ could come into play though as investors mull over the real numbers that may not be supportive of such a significant rerating.

NASDAQ surges while Trump does laps in Maryland

As Trump orchestrated a bizarre COVID convoy around his hospital digs in Maryland, US markets rallied strongly with the Dow up 465 points or 1.7% as it closed at 28,148 points.

However, once again it was the NASDAQ that shone brightest, gaining 2.3% or 257 points to close at 11,382 points, just shy of its session high.

While the mood wasn’t as bullish in Europe, all the major markets were in the black and the broader Stoxx 600 closed up 0.8%.

The FTSE 100 rallied 40 points or 0.7% to close at 5943 points.

Markets in Germany and France both gained about 1% to close at 12,828 points and 4871 points respectively.

This was a credible performance, particularly in light of heightening coronavirus fears, including misinformation regarding case numbers in the UK.

On the commodities front, oil was the standout performer with the Brent Crude Oil Continuous Contract gaining 5% to close at US$41.29 per barrel.

On the back of this development, solid gains were made by producers such as Chevron Corp and services group Caterpillar Inc.

Gold continued its rally, and it is now hovering in the vicinity of US$1920 per ounce, having gained more than US$50 per ounce in the last 10 days.

Among the base metals, copper and lead trended lower while zinc made a slight gain, breaking a four-day losing streak.

However, nickel was the big mover, increasing from US$6.47 per pound to US$6.56 per pound.

The Australian dollar strengthened overnight as it pushed up towards US$0.72.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X